Literature DB >> 22379752

Transcatheter aortic valve implantation (TAVI): first case in Thailand.

Pranya Sakiyalak1, Worawong Slisatkorn, Suwatchai Pornratanarangsi, Nattawut Wongpraparut, Decho Jakrapanichakul, Kasana Raksamani, Ungkab Prakanrattana, Pansak Laksanabunsong.   

Abstract

Aortic valve replacement (AVR) is the standard treatment for patients with symptomatic severe aortic stenosis (AS). However many patients are not offered surgery due to high surgical risk for open AVR. Transcatheter aortic valve implantation has been an alternative to open heart surgery in patients with symptomatic severe aortic stenosis (AS) who are not suitable for open surgery. The first transcatheter aortic valve implantation in Thailand via the transapical route is described. An 87-year-old woman with symptomatic severe AS, calcified aorta and peripheral arterial disease, who was at high surgical risk, was successfully treated, and had good functional and haemodynamic results at six-months follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 22379752

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis.

Authors:  Phatcharaphorn Chotnoppharatphatthara; Voratima Yoodee; Suthinee Taesotikul; Jirawit Yadee; Unchalee Permsuwan
Journal:  Eur J Health Econ       Date:  2022-06-16

2.  Preprocedural and procedural variables that predict new-onset conduction disturbances after transcatheter aortic valve replacement.

Authors:  Wongsaput Boonyakiatwattana; Adisak Maneesai; Vithaya Chaithiraphan; Decho Jakrapanichakul; Pranya Sakiyalak; Narathip Chunhamaneewat; Worawong Slisatkorn; Chunhakasem Chotinaiwattarakul; Rungtiwa Pongakasira; Nattawut Wongpraparut
Journal:  BMC Cardiovasc Disord       Date:  2022-03-31       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.